Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy

BJU International

Volumn 111, Issue 8, 2013, Pages 1199-1207

  Hurel, Sophie ^a   Rouprêt, Morgan ^b   Ouzzane, Adil ^c   Rozet, François ^d   Xylinas, Evanguelos ^e   Zerbib, Marc ^e   Berod, Alexis Arvin ^f   Ruffion, Alain ^g   Adam, Emilie ^h   Cussenot, Olivier ⁱ   Houlgatte, Alain ^j   Phé, Véronique ^k   Nouhaud, François Xavier ^l   Bensadoun, Henri ^a   Delage, Francky ^m   Guillotreau, Julien ⁿ   Guy, Laurent ^o   Karsenty, Gilles ^p   De La Taille, Alexandre ^q   Colin, Pierre ^c,r  

^a CHU CÔTE DE NACRE   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d INSTITUT MUTUALISTE MONTSOURIS   (France)

^e Institut Cochin   (France)

^f HÔPITAL MICHALLON   (France)

^g HOSPICES CIVILS DE LYON   (France)

^h EDOUARD HERRIOT HOSPITAL   (France)

ⁱ HÔPITAL TENON   (France)

^j University of Paris Descartes   (France)

^k FOCH HOSPITAL   (France)

^l HÔPITAL CHARLES NICOLLE   (France)

^m SERVICE DE RHUMATOLOGIE   (France)

ⁿ CHU RANGUEIL   (France)

^o SERVICE DE RHUMATOLOGIE   (France)

^p ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^q HENRI MONDOR HOSPITAL   (France)

^r Seclin Hospital Center   (France)

more..

Author keywords

lymphovascular invasion; nephroureterectomy; renal pelvis; survival; ureter; urothelial carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; LOW RISK POPULATION; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS FREE SURVIVAL; NEPHROURETERECTOMY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME;

AGED; CARCINOMA, TRANSITIONAL CELL; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; KIDNEY NEOPLASMS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEPHRECTOMY; PELVIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE; URETER; URETERAL NEOPLASMS;

EID: 84878281103     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12116     Document Type: Article

References (20)

1. Roupret M, Zigeuner R, Palou J, et al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol 2011; 59: 584-594
2. Stenzl A, Witjes JA, Comérat E, et al. Guidelines on bladder cancer muscle-invasive and metastatic 2012
3. Kikuchi E, Margulis V, Karakiewicz PI, et al. Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol 2009; 27: 612-618
4. Novara G, Matsumoto K, Kassouf W, et al. Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study. Eur Urol 2009; 57: 1064-1071
5. Bolenz C, Fernandez MI, Trojan L, et al. Lymphovascular invasion and pathologic tumor stage are significant outcome predictors for patients with upper tract urothelial carcinoma. Urology 2008; 72: 364-369
6. Saito K, Kawakami S, Fujii Y, Sakura M, Masuda H, Kihara K,. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically. J Urol 2007; 178: 2291-2296; discussion 2296 (Pubitemid 350052165)
7. Kikuchi E, Horiguchi Y, Nakashima J, et al. Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract. J Urol 2005; 174: 2120-2123; discussion 2124 (Pubitemid 41611749)
8. Sagalowsky A, Jarret T,. Management of urothelial tumors of the renal pelvis and ureter. In, Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, eds, Campbell-Walsh UROLOGY, Ninth edn, Vol. 2. Chapt 49. Philadelphia: Saunders Elsevier, 2007: 1653-1685
9. Sobin L, Godspodarowicz M, Wittekind C,. Renal Pelvis and Ureter. TNM Classification of Malignant Tumours Urological Tumours International Union Against Cancer. ed 7 rev. edn. New York: Wiley-Blackwell, 2009: 258-261
10. Mostofi FK, Sorbin LH, Torloni H,. International Histological Classification of Tumours: Histological Typing of Urinary Bladder Tumours, 10 edn. Geneva: World Health Organization, 1973
11. Ouzzane A, Colin P, Ghoneim TP, et al. The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract (UTUC) treated by nephroureterectomy. World J Urol 2013; 31: 789-797
12. Kondo T, Nakazawa H, Ito F, Hashimoto Y, Toma H, Tanabe K,. Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract. Urology 2007; 69: 265-269 (Pubitemid 46274933)
13. Bolenz C, Shariat SF, Fernandez MI, et al. Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density. BJU Int 2009; 103: 302-306
14. Godfrey MS, Badalato GM, Hruby GW, Razmjoo M, McKiernan JM,. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion. BJU Int 2012; 110: 798-803. doi: 10.1111/j.1464-410X.2011.10893.x
15. Colin P, Ouzzane A, Yates DR, et al. Influence of positive surgical margin status after radical nephroureterectomy on upper urinary tract urothelial carcinoma survival. Ann Surg Oncol 2012; 19: 3613-3620
16. Mason RJ, Kassouf W, Bell DG, et al. The contemporary role of lymph node dissection during nephroureterectomy in the management of upper urinary tract urothelial carcinoma: the Canadian experience. Urology 2012; 79: 840-845
17. Roscigno M, Cozzarini C, Bertini R, et al. Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract. Eur Urol 2008; 53: 794-802
18. Xylinas E, Rink M, Margulis V, et al. Prediction of true nodal status in patients with pathological lymph node negative upper tract urothelial carcinoma at radical nephroureterectomy. J Urol 2013; 189: 468-473. doi: 10.1016/j.juro.2012.09.036
19. Margulis V, Youssef RF, Karakiewicz PI, et al. Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. J Urol 2010; 184: 453-458
20. Rischmann P, Bittard H, Chopin D, et al. AFU recommendations 1998. 'Committee on Cancer of the French Association of Urology'. Prog Urol 2002; 12: 1159-1160